Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Employer
- University College London
- University of Glasgow
- UCL;
- University of Cincinnati
- Brunel University London;
- DAAD
- DURHAM UNIVERSITY
- Max Planck Institute for Human Cognitive and Brain Sciences •
- NTNU - Norwegian University of Science and Technology
- Nature Careers
- Tallinn University of Technology
- The Belgian Nuclear Research Centre
- UCL
- University of Oslo
- Vrije Universiteit Brussel (VUB)
- 5 more »
- « less
-
Field
-
Enhanced maternity, paternity and adoption pay Employee assistance programme: Staff Support Service Discounted medical insurance Visit https://www.ucl.ac.uk/work-at-ucl/rewards-and-benefits to find out more
-
pay Employee assistance programme: Staff Support Service Discounted medical insurance Visit https://www.ucl.ac.uk/work-at-ucl/rewards-and-benefits to find out more As London’s Global University, we know
-
• Employee assistance programme • Staff Support Service • Discounted medical insurance • Visit https://www.ucl.ac.uk/work-at-ucl/reward-and-benefitsto find out more As London’s Global University, we want our
-
the University College London (UCL) invites applications for a fully funded 4-year PhD program in Process Systems Engineering. The project will focus on the development of an AI-enhanced design framework for novel
-
TypeRemoteAvailable for SecondmentNoClosing Date04-May-2026JD_Param11YesJD_Param12Yes AHRC Collaborative Doctoral Partnership (CDP) studentship: Histories of Pollution in the Urban Art Museum, c. 1840–1900 (UCL and The
-
of all major fields of politics, as well as public management and public policy. More details about the Department and UCL can be found below https://www.ucl.ac.uk/social-historical-sciences/political
-
. Furthermore, in established CRC, interaction between the microbiome and immune system is thought to impact outcomes. This exciting PhD project will build on an existing highly annotated dataset of around 2600
-
impact due to severe unwanted side-effects, likely resulting from homeostatic roles of NF-κB. Thus, despite the tremendous therapeutic promise of modulating it’s activity, NF-κB remains an important target
-
) pain affects approximately 20% of the global population, however, one in three of these patients do not respond to any form of treatments that are currently available. Our failure to offer effective pain
-
of Tübingen and part of the Developmental Computational Psychiatry research group, which is located both at Tübingen and the Max Planck UCL Centre for Computational Psychiatry and Ageing Research in London. You